Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Mil Med ; 183(11-12): e721-e729, 2018 11 05.
Article in English | MEDLINE | ID: mdl-30500921

ABSTRACT

Background: Hydroxyethyl starch (Hextend) has been used for hemorrhagic shock resuscitation, however, hydroxyethyl starch may be associated with adverse outcomes. Objective: To compare systolic blood pressure (sBP) in animals that had 30% of their blood volume removed and treated with intravenous hydroxocobalamin, hydroxyethyl starch, or no fluid. Methods: Twenty-eight swine (45-55 kg) were anesthetized and instrumented with continuous femoral and pulmonary artery pressure monitoring. Animals were hemorrhaged 20 mL/kg over 20 minutes and then administered 150 mg/kg IV hydroxocobalamin in 180 mL saline, 500 mL hydroxyethyl starch, or no fluid and monitored for 60 minutes. Data were modeled using repeated measures multivariate analysis of variance. Results: There were no significant differences before treatment. At 20 minutes after hemorrhage, there was no significant difference in mean sBP between treated groups, however, control animals displayed significantly lower mean sBP (p < 0.001). Mean arterial pressure and heart rate improved in the treated groups but not in the control group (p < 0.02). Prothrombin time was longer and platelet counts were lower in the Hextend group (p < 0.05). Moreover, thromboelastography analysis showed longer clotting (K) times (p < 0.05) for the hydroxyethyl starch-treated group. Conclusion: Hydroxocobalamin restored blood pressure more effectively than no treatment and as effectively as hydroxyethyl starch but did not adversely affect coagulation.


Subject(s)
Blood Pressure , Hemorrhage , Hydroxocobalamin , Hydroxyethyl Starch Derivatives , Resuscitation , Animals , Administration, Intravenous , Blood Coagulation/drug effects , Blood Pressure/drug effects , Disease Models, Animal , Emergency Medical Services/methods , Emergency Medical Services/standards , Emergency Medical Services/statistics & numerical data , Hemorrhage/drug therapy , Hydroxocobalamin/pharmacology , Hydroxocobalamin/standards , Hydroxocobalamin/therapeutic use , Hydroxyethyl Starch Derivatives/pharmacology , Hydroxyethyl Starch Derivatives/standards , Hydroxyethyl Starch Derivatives/therapeutic use , Resuscitation/methods , Resuscitation/standards , Swine
2.
J Vet Intern Med ; 32(2): 712-721, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29377300

ABSTRACT

BACKGROUND: Tetrastarch can cause acute kidney injury (AKI) in humans with sepsis, but less likely to result in tissue edema than lactated Ringer's solution (LRS). OBJECTIVES: Compare effects of volume replacement (VR) with LRS and 6% tetrastarch solution (TS) on extravascular lung water (EVLW) and markers of AKI in hemorrhaged dogs. ANIMALS: Six healthy English Pointer dogs (19.7-35.3 kg). METHODS: Prospective crossover study. Animals underwent anesthesia without hemorrhage (Control). Two weeks later, dogs hemorrhaged under anesthesia on 2 occasions (8-week washout intervals) and randomly received VR with LRS or TS at 3 : 1 or 1 : 1 of shed blood, respectively. Anesthesia was maintained until 4 hour after VR for EVLW measurements derived from transpulmonary thermodilution cardiac output. Neutrophil gelatinase-associated lipocalin (NGAL) and creatinine concentrations in plasma and urine were measured until 72 hour after VR. RESULTS: The EVLW index (mL/kg) was lower at 1 hour after TS (10.0 ± 1.9) in comparison with controls (11.9 ± 3.4, P = 0.04), and at 4 hour after TS (9.7 ± 1.9) in comparison with LRS (11.8 ± 2.7, P = 0.03). Arterial oxygen partial pressure-to-inspired oxygen fraction ratio did not differ among treatments from 0.5 to 4 hour after VR. Urine NGAL/creatinine ratio did not differ among treatments and remained below threshold for AKI (120,000 pg/mg). CONCLUSIONS AND CLINICAL IMPORTANCE: Although TS causes less EVLW accumulation than LRS, neither fluid produced evidence of lung edema (impaired oxygenation). Both fluids appear not to cause AKI when used for VR after hemorrhage in healthy nonseptic dogs.


Subject(s)
Extravascular Lung Water/drug effects , Hydroxyethyl Starch Derivatives/pharmacology , Isotonic Solutions/pharmacology , Anesthetics, Inhalation/administration & dosage , Animals , Cardiac Output/drug effects , Creatinine/blood , Creatinine/urine , Cross-Over Studies , Dogs , Female , Hemorrhage , Hydroxyethyl Starch Derivatives/adverse effects , Isoflurane/administration & dosage , Isotonic Solutions/adverse effects , Lipocalin-2/blood , Lipocalin-2/urine , Male , Plasma Substitutes/adverse effects , Plasma Substitutes/pharmacology , Prospective Studies , Ringer's Lactate
3.
Dental press j. orthod. (Impr.) ; 20(4): 91-98, July-Aug. 2015. tab, ilus
Article in English | LILACS | ID: lil-757424

ABSTRACT

Angle Class III malocclusion is characterized by anteroposterior dental discrepancy which might be associated or not with skeletal changes. Class III molar relationship is associated with vertical or lingually tipped mandibular incisors and a usually concave profile. These characteristics seriously affect facial esthetics and most frequently are the reason why patients seek orthodontic treatment. This case was presented to the committee of the Brazilian Board of Orthodontics and Facial Orthopedics (BBO) as part of the requisites to become a BBO Diplomate.


A má oclusão de Classe III de Angle é caracterizada por uma discrepância dentária anteroposterior, que pode ou não estar acompanhada por alterações esqueléticas. Observa-se uma relação molar de Classe III associada ao posicionamento vertical ou retroinclinado dos incisivos inferiores e, geralmente, perfil facial côncavo. Esse aspecto gera grande comprometimento estético na face, sendo justamente esse o fator que, na maioria das vezes, motiva o paciente a procurar pelo tratamento ortodôntico. O presente caso clínico foi apresentado à Diretoria do Board Brasileiro de Ortodontia e Ortopedia Facial (BBO) como parte dos requisitos para a obtenção do título de Diplomado pelo BBO.


Subject(s)
Animals , Blood Pressure/drug effects , Dogs , Hydroxyethyl Starch Derivatives/pharmacology , Hypotension/veterinary , Isoflurane/adverse effects , Isotonic Solutions/pharmacology , Anesthetics, Inhalation/adverse effects , Dog Diseases/drug therapy , Hydroxyethyl Starch Derivatives/administration & dosage , Hypotension/therapy , Isoflurane/pharmacology , Plasma Substitutes/administration & dosage , Plasma Substitutes/therapeutic use
4.
Genet Mol Res ; 14(2): 6649-63, 2015 Jun 18.
Article in English | MEDLINE | ID: mdl-26125873

ABSTRACT

The effects of goal-directed fluid therapy, with lactated Ringer's (LR) and 6% hydroxyethyl starch (HES) solution, on hemorrhagic shock dogs are unknown. We aimed to determine the optimal LR: HES ratio for the resuscitation of hemorrhagic shock dogs. Hemorrhagic shock was induced in 40 ventilated dogs by drawing an estimated 60% blood volume. The animals were randomly divided into five groups (N = 8) according to the LR: HES ratio of the resuscitation fluid (3:1, 2:1, 1:1, 1:2, and 1:3), and were then resuscitated for 24 h to reach the stroke volume variation (SVV) and hemoglobin (Hb) goals by fluid infusion and autologous blood perfusion. The extravascular lung water index (EVLWI), pH, partial pressure of oxygen (PaO2), base excess (BE), sodium, chloride, Hb and creatinine clearance (Clearcrea) were checked after 24 h (R24). The EVLWI of the 3:1 group at R24 were higher than that of the 1:3 group and the baseline value (P < 0.05), whereas the PaO2 was lower (P < 0.05). In contrast to the 3:1 group at R24 and baseline, plasma chloride and sodium in the 1:3 and 1:2 groups increased; however, pH, BE, and Clearcrea decreased (P < 0.05). No significant differences were found in the 1:1 and 2:1 groups at R24 compared with baseline (P > 0.05). Resuscitation with LR and HES at 2:1 and 1:1 ratios are superior in maintaining the acid-base, electrolyte, and lung water balances as well as renal function in hemorrhagic shock dogs than at ratios of 3:l, 1:2, and1:3.


Subject(s)
Fluid Therapy/methods , Hydroxyethyl Starch Derivatives/pharmacology , Isotonic Solutions/pharmacology , Resuscitation/methods , Shock, Hemorrhagic/therapy , Acid-Base Equilibrium/drug effects , Animals , Blood Transfusion, Autologous , Chlorides/blood , Dogs , Hemoglobins/metabolism , Kidney Function Tests , Oxygen Consumption/drug effects , Respiration, Artificial , Ringer's Lactate , Shock, Hemorrhagic/blood , Shock, Hemorrhagic/pathology , Sodium/blood , Stroke Volume/drug effects
5.
Acta Cir Bras ; 30(6): 407-13, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26108029

ABSTRACT

PURPOSE: Vogt´s antioxidant solution (red blood cells, Ringer's solution, sodium bicarbonate, mannitol, allopurinol and 50% glucose) or its modification including hydroxyethyl starch (HES) were tested for the prevention of splanchnic artery occlusion shock. METHODS: Seventy rats were distributed in treatment (3), control (1), and sham (3) groups. Ischemia and reperfusion were induced by celiac, superior mesenteric and inferior mesenteric arteries occlusion for 40 min, followed by 60 min reperfusion or sham procedures. Controls received saline, both treatment and sham groups received the Vogt's solution, modified Vogt's solution (replacing Ringer's solution by HES), or HES. Mean arterial blood pressure (MABP), ileal malondialdehyde (MDA) and plasmatic MDA were determined, and a histologic grading system was used. RESULTS: At reperfusion, MABP dropped in all I/R groups. Only HES treatment was able to restore final MABP to the levels of sham groups. Plasmatic MDA did not show differences between groups. Ileum MDA was significantly higher in the control and treatment groups as compared to the sham group. Histology ranking was higher in the only in control group. CONCLUSIONS: Hydroxyethyl starch was able to prevent hemodynamic shock but not intestinal lesions. Both treatments with Vogt's solutions did not show any improvement.


Subject(s)
Hydroxyethyl Starch Derivatives/pharmacology , Mesenteric Arteries/drug effects , Mesenteric Vascular Occlusion/prevention & control , Plasma Substitutes/pharmacology , Reperfusion Injury/prevention & control , Animals , Disease Models, Animal , Hemodynamics/drug effects , Hydroxyethyl Starch Derivatives/therapeutic use , Ileum/blood supply , Ileum/pathology , Ischemia/prevention & control , Isotonic Solutions/pharmacology , Isotonic Solutions/therapeutic use , Male , Malondialdehyde/analysis , Mesenteric Arteries/pathology , Mesenteric Vascular Occlusion/pathology , Plasma Substitutes/therapeutic use , Rats, Wistar , Reproducibility of Results , Splanchnic Circulation/drug effects , Time Factors , Treatment Outcome
6.
Acta cir. bras ; Acta cir. bras;30(6): 407-413, 06/2015. tab, graf
Article in English | LILACS | ID: lil-749649

ABSTRACT

PURPOSE: Vogt´s antioxidant solution (red blood cells, Ringer's solution, sodium bicarbonate, mannitol, allopurinol and 50% glucose) or its modification including hydroxyethyl starch (HES) were tested for the prevention of splanchnic artery occlusion shock. METHODS: Seventy rats were distributed in treatment (3), control (1), and sham (3) groups. Ischemia and reperfusion were induced by celiac, superior mesenteric and inferior mesenteric arteries occlusion for 40 min, followed by 60 min reperfusion or sham procedures. Controls received saline, both treatment and sham groups received the Vogt's solution, modified Vogt's solution (replacing Ringer's solution by HES), or HES. Mean arterial blood pressure (MABP), ileal malondialdehyde (MDA) and plasmatic MDA were determined, and a histologic grading system was used. RESULTS: At reperfusion, MABP dropped in all I/R groups. Only HES treatment was able to restore final MABP to the levels of sham groups. Plasmatic MDA did not show differences between groups. Ileum MDA was significantly higher in the control and treatment groups as compared to the sham group. Histology ranking was higher in the only in control group. CONCLUSIONS: Hydroxyethyl starch was able to prevent hemodynamic shock but not intestinal lesions. Both treatments with Vogt's solutions did not show any improvement. .


Subject(s)
Animals , Male , Hydroxyethyl Starch Derivatives/pharmacology , Mesenteric Arteries/drug effects , Mesenteric Vascular Occlusion/prevention & control , Plasma Substitutes/pharmacology , Reperfusion Injury/prevention & control , Disease Models, Animal , Hemodynamics/drug effects , Hydroxyethyl Starch Derivatives/therapeutic use , Ileum/blood supply , Ileum/pathology , Ischemia/prevention & control , Isotonic Solutions/pharmacology , Isotonic Solutions/therapeutic use , Malondialdehyde/analysis , Mesenteric Arteries/pathology , Mesenteric Vascular Occlusion/pathology , Plasma Substitutes/therapeutic use , Rats, Wistar , Reproducibility of Results , Splanchnic Circulation/drug effects , Time Factors , Treatment Outcome
7.
J Surg Res ; 169(1): 132-8, 2011 Jul.
Article in English | MEDLINE | ID: mdl-20338587

ABSTRACT

BACKGROUND: Hydroxyethylstarch (HES) is a synthetic polymer of glucose that has been suggested for therapeutic use in long-term plasma expansion. The aim of this study was to test the hypothesis that the infusion of a small volume of HES may provide benefits in systemic and regional hemodynamics and metabolism in a brain-dead canine model compared with large volume crystalloid resuscitation. METHODS: Fourteen mongrel dogs were subjected to a brain-death protocol by consecutive insufflations of a balloon catheter in the epidural space. One hour after induction of brain-death, the animals were randomly assigned to two groups: NS (0.9% NaCl, 33 mL/kg), and HES (6%HES 450/0.7, 17 mL/Kg). Systemic and regional hemodynamics were evaluated using Swan-Ganz, ultrasonic flowprobes, and arterial catheters. Serial blood samples were collected for blood gas, electrolyte, and serum chemistry analysis. Systemic, hepatic, and splanchnic O(2)-derived variables were also calculated. RESULTS: Epidural balloon insufflations induced a significant increase in mean arterial pressure, cardiac output (MAP and CO, respectively), regional blood flow, and systemic vascular resistance. Following the hyperdynamic phase, severe hypotension with normalization of systemic and regional blood flow was observed. Fluid resuscitation induced a prompt increase in MAP, CO, and portal vein blood flow, and a significant reduction in systemic and pulmonary vascular resistance. There were no differences between groups in metabolic indices, liver function tests (LFTs), or renal function tests. HES was more effective than NS in restoring cardiac performance in the first 2h after fluid resuscitation (P < 0.05). Both tested solutions partially and temporarily restored systemic and regional oxygen delivery. CONCLUSION: Small volumes of 6% HES 450/0.7 improved cardiovascular performance and provided the same regional hemodynamic and metabolic benefits of large volumes of isotonic crystalloid solutions.


Subject(s)
Brain Death/metabolism , Brain Death/physiopathology , Hemodynamics/drug effects , Hydroxyethyl Starch Derivatives/pharmacology , Plasma Substitutes/pharmacology , Resuscitation/methods , Alanine Transaminase/metabolism , Animals , Blood Pressure/drug effects , Blood Pressure/physiology , Cardiac Output/drug effects , Cardiac Output/physiology , Creatine Kinase/metabolism , Dogs , Glucose/metabolism , Male , Models, Animal , Regional Blood Flow/drug effects , Regional Blood Flow/physiology , Sodium Chloride/pharmacology , Vascular Resistance/drug effects , Vascular Resistance/physiology
8.
Rev. chil. cir ; 62(5): 532-539, oct. 2010. tab
Article in Spanish | LILACS | ID: lil-577295

ABSTRACT

Hextend® is a preparation of hetilstarch in a balanced electrolyte solution that contains 143 mEq/L of sodium, 124mEq/L of chloride, 5 mEq/L of calcium 3 mEq/L of potassium 0.9 mEq/L of magnesium, 0.99 g/L of glucose and 24 mEq/L of lactate. It has a volume of distribution similar to blood volume which enables it to stay in the intravascular compartment until it is renally cleared or absorbed by the reticuloendothelial system. It shows a bimodal pattern of clearance with a half life during the first 8 hrs of its infusion of 4.2 hrs and during the 7 days following of 38.2 hrs. Hextend® is currently one of the preferred resuscitation solutions in the hypovolemic patient showing a better profile of effects over hemostasis and acid base status and conferring a better survival over similar patients resuscitated with crystalloids or other synthetic colloids. Hextend® provides an adequate fluid that is effective in the resuscitation of the trauma patient in hypovolemic hemorrhagic shock and promises to become the fluid of choice in the routine management of these patients. There is a need of more randomized prospective studies in the field of trauma using Hextend ® and its combination with the inflammatory cascade modifiers such as ethyl pyruvate among others.


Hextend® es una combinación de hetilalmidón balanceada en una solución de electrolitos que contiene 143 mEq/L de sodio, 124 mEq/L de cloro, 5 mEq/L de calcio, 3 mEq/L de potasio, 0,9 mEq/L de magnesio, 0,99 g/L de glucosa y 24 mEq/L de lactato. Posee un volumen de distribución equivalente al volumen sanguíneo manteniéndose en el compartimento vascular hasta ser excretado vía renal o absorbido por el sistema retículo-endotelial. Estas características le confieren un patrón farmacocinético bimodal con una vida media de 4,2 horas durante las primeras 8 hrs de infusión y de 38,2 h durante los primeros 7 días. Hextend® es actualmente una de las soluciones de reanimación con mejor perfil de efectos sobre la hemostasia y el equilibrio ácido base del paciente en choque hipovolémico y confiere un aumento de la sobrevida, comparado con controles resucitados con cristaloides u otros coloides sintéticos. Esta combinación de hetilalmidón en una solución amortiguadora electrolítica posee mínimos efectos sobre la función hemostática y plaquetaria por lo que actualmente es preferido frente a soluciones cristaloides y otros coloides utilizados en el pasado en la reanimación de pacientes politraumatizados en estado de choque hipovolémico hemorrágico. A su vez, promete transformarse en el fluido de elección en el manejo rutinario de estos pacientes. En relación al uso de este producto es imperativo realizar un mayor número de estudios prospectivos randomizados. La literatura internacional augura un esplendoroso futuro al uso de Hextend®, como también a su posible combinación con modificadores de la cascada inflamatoria, entre otros con el etil piruvato.


Subject(s)
Humans , Electrolytes/administration & dosage , Hemostasis , Hydroxyethyl Starch Derivatives/administration & dosage , Shock/drug therapy , Plasma Substitutes/administration & dosage , Electrolytes/pharmacology , Electrolytes/chemistry , Acid-Base Equilibrium , Hydroxyethyl Starch Derivatives/pharmacology , Hydroxyethyl Starch Derivatives/chemistry , Blood Platelets , Resuscitation , Plasma Substitutes/pharmacology , Plasma Substitutes/chemistry
9.
J Crit Care ; 25(4): 659.e1-8, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20813485

ABSTRACT

PURPOSE: The aim of this study was to show that 6% hydroxyethyl starch (HES) 130/0.4 achieves a better resuscitation of the microcirculation than normal saline solution (SS), during early goal-directed therapy (EGDT) in septic patients. MATERIALS AND METHODS: Patients with severe sepsis were randomized for EGDT with 6% HES 130/0.4 (n = 9) or SS (n = 11). Sublingual microcirculation was evaluated by sidestream dark field imaging 24 hours after the beginning of EGDT. RESULTS: On admission, there were no differences in Sequential Organ Failure Assessment score, mean arterial pressure, lactate, or central venous oxygen saturation. After 24 hours, no difference arose in those parameters. Sublingual capillary density was similar in both groups (21 ± 8 versus 20 ± 3 vessels/mm(2)); but capillary microvascular flow index, percent of perfused capillaries, and perfused capillary density were higher in 6% HES 130/0.4 (2.5 ± 0.5 versus 1.6 ± 0.7, 84 ± 15 versus 53 ± 26%, and 19 ± 6 versus 11 ± 5 vessels/mm(2), respectively, P < .005). CONCLUSIONS: Fluid resuscitation with 6% HES 130/0.4 may have advantages over SS to improve sublingual microcirculation. A greater number of patients would be necessary to confirm these findings.


Subject(s)
Fluid Therapy , Hydroxyethyl Starch Derivatives/therapeutic use , Microcirculation/drug effects , Plasma Substitutes/therapeutic use , Resuscitation/methods , Sepsis/therapy , Sodium Chloride/therapeutic use , Adult , Aged , Aged, 80 and over , Female , Humans , Hydroxyethyl Starch Derivatives/chemistry , Hydroxyethyl Starch Derivatives/pharmacology , Male , Middle Aged , Mouth Floor/blood supply , Pilot Projects , Plasma Substitutes/chemistry , Plasma Substitutes/pharmacology , Sodium Chloride/pharmacology
10.
Rev. chil. cir ; 62(4): 419-423, ago. 2010.
Article in Spanish | LILACS | ID: lil-565373

ABSTRACT

Hemorrhagic hypovolemic shock secondary to trauma is an important cause of morbidity and mortality worldwide. During the last few years, new concepts have emerged and the guidelines of fluid resuscitation in these patients have been redefined. The concept of hypotensive resuscitation has been established and new colloid solutions based on starch have been manufactured, been hydroxyethyl starch in a balanced electrolytic solution, the most studied and successful one. It has been reported, as well, the positive effects of the pharmacologic modulation of the inflammatory pathways in experimental model subjects submitted to hypovolemic shock. Products such as, ethyl pyruvate and the Na+/H+ type 1 inhibitor, BIIB513, have been Studies only experimentally in rodent models using colloids as the primary resuscitation fluid. The significant improvement in the hemodinamyc, pattern and the cardiac and inflammatory indexes and mediators, has created the basis for their use in clinical trials in the near future. The systemic inflammatory response is an important cause of multiple organ failure that increases the late mortality of patients surviving the initial early phases of hypovolemic traumatic shock and its experimental modulation in rodent models with products such as ethyl pyruvate and BIIB513 has produced excellent in vivo and in vitro results.


Universalmente se considera el Shock hipovolémico de origen hemorrágico como una importante causa de morbi-mortalidad. Durante los últimos años se ha redefinido los conceptos de la reanimación con líquidos intravenosos en los pacientes con choque hipovolémico y establecido los conceptos de reanimación hipotensa con el uso de nuevos coloides derivados del almidón, tales como el hidroxietil-almidón en solución electrolítica balanceada (Hextend®). Así mismo, se ha reportado el beneficio que conlleva el uso de modificadores de la cascada inflamatoria en modelos experimentales de sujetos sometidos a choque hipovolémico hemorrágico. Productos como el etil piruvato y la BIIB513, un inhibidor selectivo del intercambiador Na+/H+ tipo 1, han sido estudiados sólo experimentalmente en modelos roedores, empleando coloides como principal elemento de reanimación. Al mejorar el perfil hemodinámico, parámetros cardíacos y niveles de mediadores inflamatorios, estos compuestos constituyen una base cierta para ser incluidos en estudios clínicos en un futuro próximo. La respuesta inflamatoria sistémica está íntimamente implicada en la patogénesis de la Falla Orgánica Múltiple, aumentando la mortalidad tardía de pacientes que sobreviven las etapas tempranas del shock hipovolémico hemorrágico traumático. Su modulación experimental con el etil piruvato o bien la BIIB513 ha dado excelente resultado tanto en modelos experimentales in vivo como in vitro.


Subject(s)
Humans , Sodium-Hydrogen Exchangers/antagonists & inhibitors , Hydroxyethyl Starch Derivatives/pharmacology , Mesylates/pharmacology , Shock/drug therapy , Isotonic Solutions/pharmacology , Hemodynamics , Wounds and Injuries/complications , Inflammation , Resuscitation/methods , Shock, Hemorrhagic/etiology , Shock, Hemorrhagic/drug therapy , Shock/etiology , Plasma Substitutes/pharmacology
11.
J Trauma ; 67(6): 1225-32; discussion 1232, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20009671

ABSTRACT

BACKGROUND: Different hemodynamic parameters including static indicators of cardiac preload as right ventricular end-diastolic volume index (RVEDVI) and dynamic parameters as pulse pressure variation (PPV) have been used in the decision-making process regarding volume expansion in critically ill patients. The objective of this study was to compare fluid resuscitation guided by either PPV or RVEDVI after experimentally induced hemorrhagic shock. METHODS: Twenty-six anesthetized and mechanically ventilated pigs were allocated into control (group I), PPV (group II), or RVEDVI (group III) group. Hemorrhagic shock was induced by blood withdrawal to target mean arterial pressure of 40 mm Hg, maintained for 60 minutes. Parameters were measured at baseline, time of shock, 60 minutes after shock, immediately after resuscitation with hydroxyethyl starch 6% (130/0.4), 1 hour and 2 hours thereafter. The endpoint of fluid resuscitation was determined as the baseline values of PPV and RVEDVI. Statistical analysis of data was based on analysis of variance for repeated measures followed by the Bonferroni test (p < 0.05). RESULTS: Volume and time to resuscitation were higher in group III than in group II (group III = 1,305 +/- 331 mL and group II = 965 +/- 245 mL, p < 0.05; and group III = 24.8 +/- 4.7 minutes and group II = 8.8 +/- 1.3 minutes, p < 0.05, respectively). All static and dynamic parameters and biomarkers of tissue oxygenation were affected by hemorrhagic shock and nearly all parameters were restored after resuscitation in both groups. CONCLUSION: In the proposed model of hemorrhagic shock, resuscitation to the established endpoints was achieved within a smaller amount of time and with less volume when guided by PPV than when guided by pulmonary artery catheter-derived RVEDVI.


Subject(s)
Blood Pressure/physiology , Diastole/physiology , Fluid Therapy/methods , Resuscitation/methods , Shock, Hemorrhagic/physiopathology , Shock, Hemorrhagic/therapy , Analysis of Variance , Animals , Biomarkers/analysis , Blood Volume , Disease Models, Animal , Echocardiography, Transesophageal , Extravascular Lung Water/physiology , Heart Rate/physiology , Hemodynamics , Hydroxyethyl Starch Derivatives/pharmacology , Random Allocation , Swine , Treatment Outcome
12.
Acta Cir Bras ; 24(2): 87-92, 2009.
Article in English | MEDLINE | ID: mdl-19377775

ABSTRACT

PURPOSE: To investigate hemodynamic response to volume replacement with saline solution and hypertonic hydroxyethyl starch in hypovolemic dogs. METHODS: Forty dogs under general anesthesia and hemodynamic monitoring, following measurements at baseline, were bled 20 ml x Kg(-1) and parameters were measured again after 10 minutes. The animals were randomly divided in two groups and volume replacement was performed with saline solution twice the volume removed or 4 ml x Kg(-1) of hypertonic hydroxyethyl starch. Hemodynamic data were again measured after 5, 15, 30, 45 and 60 minutes. RESULTS: With both solutions values returned to satisfactory hemodynamic levels. With saline solution, there was a greater amplitude in variations that tended to decrease progressively. With hypertonic hydroxyethyl starch, the parameters studied returned more rapidly to levels similar to those at baseline and varied less. CONCLUSION: Both solutions proved to be efficient at replacing volume in the short period studied, although hypertonic hydroxyethyl starch produced more stable results.


Subject(s)
Hemodynamics/drug effects , Hydroxyethyl Starch Derivatives/pharmacology , Hypovolemia/therapy , Plasma Substitutes/pharmacology , Saline Solution, Hypertonic/pharmacology , Animals , Blood Pressure , Disease Models, Animal , Dogs , Drug Evaluation, Preclinical , Female , Fluid Therapy , Hydroxyethyl Starch Derivatives/therapeutic use , Male , Plasma Substitutes/therapeutic use
13.
Acta cir. bras ; Acta cir. bras;24(2): 87-92, Mar.-Apr. 2009. tab
Article in English | LILACS | ID: lil-511320

ABSTRACT

PURPOSE: To investigate hemodynamic response to volume replacement with saline solution and hypertonic hydroxyethyl starch in hypovolemic dogs. METHODS: Forty dogs under general anesthesia and hemodynamic monitoring, following measurements at baseline, were bled 20 ml.Kg-1 and parameters were measured again after 10 minutes. The animals were randomly divided in two groups and volume replacement was performed with saline solution twice the volume removed or 4 ml.Kg-1 of hypertonic hydroxyethyl starch. Hemodynamic data were again measured after 5, 15, 30, 45 and 60 minutes. RESULTS: With both solutions values returned to satisfactory hemodynamic levels. With saline solution, there was a greater amplitude in variations that tended to decrease progressively. With hypertonic hydroxyethyl starch, the parameters studied returned more rapidly to levels similar to those at baseline and varied less. CONCLUSION: Both solutions proved to be efficient at replacing volume in the short period studied, although hypertonic hydroxyethyl starch produced more stable results.


OBJETIVO: Avaliar em cães hipovolêmicos as respostas hemodinâmicas da reposição volêmica com solução salina e hidroxi-etil amido hipertônico. MÉTODOS: Quarenta cães sob anestesia geral e monitorização hemodinâmica, após medidas em repouso foram sangrados 20 ml.Kg-1 e tiveram os parâmetros novamente medidos após 10 minutos. Os animais foram aleatoriamente divididos em dois grupos nos quais foi realizada reposição volêmica com solução fisiológica duas vezes o volume retirado ou 4 ml.Kg-1 de hidroxi-etil amido hipertônico e os dados hemodinâmicos medidos novamente após 5, 15, 30, 45 e 60 minutos. RESULTADOS: A reposição volêmica com as duas soluções fez os valores retornarem a níveis hemodinâmicos satisfatórios, a amplitude das variações com solução fisiológica foi maior, mas tendeu a diminuir progressivamente, com o hidroxi-etil amido hipertônico os parâmetros estudados retornaram a semelhantes ao repouso mais rapidamente e variaram menos. CONCLUSÃO: Ambas soluções se mostraram eficientes na reposição volêmica, o hidroxi-etil amido hipertônico proporcionou resultados mais estáveis.


Subject(s)
Animals , Dogs , Female , Male , Hemodynamics/drug effects , Hydroxyethyl Starch Derivatives/pharmacology , Hypovolemia/therapy , Plasma Substitutes/pharmacology , Saline Solution, Hypertonic/pharmacology , Blood Pressure , Disease Models, Animal , Drug Evaluation, Preclinical , Fluid Therapy , Hydroxyethyl Starch Derivatives/therapeutic use , Plasma Substitutes/therapeutic use
14.
J Surg Res ; 136(1): 98-105, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16815449

ABSTRACT

BACKGROUND: Considering the renal effects of fluid resuscitation in hemorrhaged patients, the choice of fluid has been a source of controversy. In a model of hemorrhagic shock, we studied the early hemodynamic and renal effects of fluid resuscitation with lactated Ringer's (LR), 6% hydroxyethyl starch (HES), and 7.5% hypertonic saline (HS) with or without 6% dextran-70 (HSD). MATERIALS AND METHODS: Forty-eight dogs were anesthetized and submitted to splenectomy. An estimated 40% blood volume was removed to maintain mean arterial pressure (MAP) at 40 mm Hg for 30 min. The dogs were divided into four groups: LR, in a 3:1 ratio to removed blood volume; HS, 6 mL kg(-1); HSD, 6 mL kg(-1); and HES in a 1:1 ratio to removed blood volume. Hemodynamics and renal function were studied during shock and 5, 60, and 120 min after fluid replacement. RESULTS: Shock treatment increased MAP similarly in all groups. At 5 min, cardiac filling pressures and cardiac performance indexes were higher for LR and HES but, after 120 min, there were no differences among groups. Renal blood flow and glomerular filtration rate (GFR) were higher in LR at 60 min but GFR returned to baseline values in all groups at 120 min. Diuresis was higher for LR at 5 min and for LR and HES at 60 min. There were no differences among groups in renal variables 120 min after treatment. CONCLUSIONS: Despite the immediate differences in hemodynamic responses, the low-volume resuscitation fluids, HS and HSD, are equally effective to LR and HES in restoring renal performance 120 min after hemorrhagic shock treatment.


Subject(s)
Hydroxyethyl Starch Derivatives/pharmacology , Isotonic Solutions/pharmacology , Plasma Substitutes/pharmacology , Resuscitation/methods , Shock, Hemorrhagic/therapy , Anesthesia , Animals , Blood Pressure , Dextrans/pharmacology , Disease Models, Animal , Dogs , Female , Fluid Therapy/methods , Kidney/blood supply , Kidney/physiology , Male , Pulmonary Wedge Pressure , Ringer's Lactate , Saline Solution, Hypertonic/pharmacology , Vascular Resistance , Ventricular Pressure
15.
Shock ; 24(4): 388-95, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16205326

ABSTRACT

Acute normovolemic hemodilution (ANH) has been proposed to avoid the risks of allogenic transfusion. In reference to its cellular effects, ANH reports in the literature are scarce. Using electron microscopy (EM), we evaluated the effects of ANH on cardiac function and myocardial structure. Twenty-five dogs were prospectively randomized to a control group (n = 5) or to undergo ANH with 6% hydroxyethyl starch (HES; n = 10) or lactated Ringer's solution (LR; n = 10) administered, respectively, at a ratio of 1:1 or 1:3 to the volume of blood removed. Animals were gradually hemodiluted to a hematocrit of 10%, which was accomplished in 80 min. Pulmonary artery catheter and echocardiography were used to evaluate cardiac function. Myocardial samples were taken after the last time point for electron microscopy analysis. Data were obtained during five different stages of ANH, with a mean 20-min interval between each time point. Cardiac index increased significantly in both groups during ANH. A significant decrease in oxygen delivery and oxygen consumption, as well as an increase in oxygen extraction was verified in the LR group. Echocardiography demonstrated a decline in systolic function in the LR group at the end of the experiment. Electron microscopy analysis of the myocardium revealed slight lesions in cardiac cells in the HES group, and moderate-to-significant lesions in the LR group. In this animal species, ANH with HES resulted in better preservation of cardiac function, which was demonstrated by maintenance of systolic function and oxygenation parameters. Minor loss of cellular integrity with HES, in the presence of very low levels of hemoglobin, reinforces these findings.


Subject(s)
Blood Transfusion/methods , Hydroxyethyl Starch Derivatives/pharmacology , Isotonic Solutions/pharmacology , Myocardium/pathology , Animals , Body Weight , Dogs , Echocardiography , Hemodilution , Hemodynamics , Microscopy, Electron , Muscle Cells/pathology , Muscle Cells/ultrastructure , Oxygen/chemistry , Oxygen/metabolism , Oxygen Consumption , Plasma Substitutes/chemistry , Ringer's Lactate , Spleen/pathology , Systole , Time Factors , Transplantation, Homologous/methods
16.
Rev. Fac. Med. UNAM ; 41(6): 227-30, nov.-dic. 1998. ilus
Article in Spanish | LILACS | ID: lil-234042

ABSTRACT

El choque circulatorio se caracteriza por perfusión tisular inadecuada lo cual resulta en disfunción celular con el consecuente metabolismo anaerobio, acidosis láctica y, de no ser tratado en forma temprana, muerte celular. La sobrevida de estos pacientes depende de compensar el gran déficit de oxigeno, optimizando la relación aporte consumo de oxígeno así como con el resto de variables cardiorespiratorias. Para lograr esto se requiere de repletar en forma adecuada el volumen circulante. La reanimación del paciente en estado de choque ha sido objeto de múltiples estudios y para lograrla se utilizan en la practica clínica: a)Cristaloides: Solución salina y Ringer lactado. b) Coloides: de origen humano (albúmina) o sintéticos (dextranes, gelatinas y hidroxietilalmidones destacan por sus características farmacológicas y clínicas, siendo un poco conocidos por la mayoría de los médicos


Subject(s)
Humans , Burns/drug therapy , Shock, Septic/drug therapy , Hemodilution , Hydroxyethyl Starch Derivatives/adverse effects , Hydroxyethyl Starch Derivatives/pharmacology , Hydroxyethyl Starch Derivatives/therapeutic use , Shock/drug therapy , Thoracic Surgery
SELECTION OF CITATIONS
SEARCH DETAIL